These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3462442)

  • 1. A pharmacokinetic study of adriamycin and 4'epi-adriamycin after simultaneous intra-arterial liver administration.
    Eksborg S; Andersson M; Domellöf L; Lönroth U
    Med Oncol Tumor Pharmacother; 1986; 3(2):105-10. PubMed ID: 3462442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration.
    Eksborg S; Stendahl U; Lönroth U
    Eur J Clin Pharmacol; 1986; 30(5):629-31. PubMed ID: 3463510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of anthracyclines.
    Eksborg S
    Acta Oncol; 1989; 28(6):873-6. PubMed ID: 2611038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic and intravenous administration of adriamycin--a comparative pharmacokinetic study in patients with malignant liver tumours.
    Eksborg S; Cedermark BJ; Strandler HS
    Med Oncol Tumor Pharmacother; 1985; 2(1):47-54. PubMed ID: 4058077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and central haemodynamic effects of doxorubicin and 4'epi-doxorubicin in the pig.
    Andersson M; Domellöf L; Eksborg S; Häggmark S; Johansson G; Reiz S; Herslöf A
    Acta Oncol; 1989; 28(5):709-14. PubMed ID: 2590548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of 4'epi-adriamycin for advanced hypernephroma.
    Benedetto P; Ahmed T; Needles B; Watson RC; Yagoda A
    Am J Clin Oncol; 1983 Oct; 6(5):553-4. PubMed ID: 6577784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of anthracyclines in dogs: evidence for structure-related body distribution and reduction to their hydroxy metabolites.
    Oosterbaan MJ; Dirks RJ; Vree TB; van der Kleijn E
    Pharm Res; 1984 Jan; 1(1):33-8. PubMed ID: 24277182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of 4'epi-doxorubicin.
    Ferrazzi E; Nicoletto O; Vinante O; Pagnin P; Maraglino G; Ganzina F; Fiorentino MV
    Tumori; 1982 Oct; 68(5):431-5. PubMed ID: 6960591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced ovarian cancer: a randomised trial comparing adriamycin or 4'epi-adriamycin in combination with cisplatin and cyclophosphamide.
    Bezwoda WR
    Med Pediatr Oncol; 1986; 14(1):26-9. PubMed ID: 3512971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II evaluation of 4'epi-doxorubicin in patients with metastatic colorectal carcinoma.
    Ferrazzi E; Pappagallo GL; Nicoletto O; Fornasiero A; Refatti F; Cartei G; Vinante O; Fiorentino MV
    Tumori; 1984 Jun; 70(3):297-300. PubMed ID: 6588671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of 4'epi-doxorubicin in human tissues.
    Italia C; Paglia L; Trabattoni A; Luchini S; Villas F; Beretta L; Marelli G; Natale N
    Br J Cancer; 1983 Apr; 47(4):545-7. PubMed ID: 6573906
    [No Abstract]   [Full Text] [Related]  

  • 12. Lattice intrahepatic doxorubicin with and without in-flow occlusion: a pharmacokinetic study of direct liver injection.
    Averbach A; Stuart OA; Chang D; Sugarbaker PH
    Eur J Surg Oncol; 2000 Feb; 26(1):73-9. PubMed ID: 10718184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic study of i.v. infusions of adriamycin.
    Eksborg S; Strandler HS; Edsmyr F; Näslund I; Tahvanainen P
    Eur J Clin Pharmacol; 1985; 28(2):205-12. PubMed ID: 3987800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isotopic ventriculography in the follow-up of cardiotoxicity induced by 4'epi-adriamycin].
    Casáns I; Lluch A; Jimeno J; Ciudad J; Losada A; García-Conde J; Belloch V
    Rev Esp Cardiol; 1988; 41 Suppl 2():89-96. PubMed ID: 3238152
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrahepatic arterial administration of 4'epidoxorubicin (epirubicin) in advanced cancer patients. A pharmacokinetic study.
    Pannuti F; Camaggi CM; Strocchi E; Comparsi R; Rossi AP; Angelelli B; Franchini A
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1309-14. PubMed ID: 3470178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim results of intra-arterial 4'-epi-doxorubicin for liver metastases.
    Simoni G; Nobile MT; Repetto M; Percivale PL; Razzi S; Tatarek R; Vidili MG; Muggianu M; Civalleri D
    Recent Results Cancer Res; 1988; 110():175-7. PubMed ID: 3165538
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols.
    Greene RF; Collins JM; Jenkins JF; Speyer JL; Myers CE
    Cancer Res; 1983 Jul; 43(7):3417-21. PubMed ID: 6850648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic analyses of intra-arterial and intra-portal chemotherapeutic agent infusion].
    Terashima M; Takagane A; Ikeda K; Abe K; Araya M; Nishizuka S; Yonezawa H; Irinoda T; Saito K
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1499-501. PubMed ID: 8854789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.